NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED) Medication Singapore | Shim Clinic
| Help me about NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED) Medication ! |
| Permalink: https://shimclinic.sg/meds/nuvaxovid-dispersion-for-injection-covid-19-vaccine-5-%c2%b5g-dose-recombinant-adjuvanted |
NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED) is a medication in Singapore. The dosage in INJECTION, SUSPENSION form, is administered by the INTRAMUSCULAR route. The licence is held by PHARMENG TECHNOLOGY PTE. LTD., approved on 1970-01-01, with the number SIN16886P. The forensic classification is Prescription Only, and ATC code is J07BN04.
Medications > Product name > NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED)
- Licence number: SIN16886P
- Product name: NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED)
- License holder: PHARMENG TECHNOLOGY PTE. LTD.
- Approval date: 1970-01-01
- Forensic classification: Prescription Only
- ATC Code: J07BN04
- Dosage form: INJECTION, SUSPENSION
- Route of Administration: INTRAMUSCULAR
- Manufacturer & Country of manufacturer:
- Active ingredients & Strength:
References